(Q52661092)

5 May 2018

title

Molecular characterization and functional expression of equine interleukin-1 type I and type II receptor cDNAs. (English)

1 reference

5 May 2018

author name string

Rikio Kirisawa

1

1 reference

5 May 2018

Norikazu Hashimoto

2

1 reference

5 May 2018

Mizuho Tazaki

3

1 reference

5 May 2018

Hitoki Yamanaka

4

1 reference

5 May 2018

Risako Ishii

5

1 reference

5 May 2018

Katsuro Hagiwara

6

1 reference

5 May 2018

Hiroshi Iwai

7

1 reference

5 May 2018

publication date

19 September 2005

1 reference

5 May 2018

Veterinary Immunology and Immunopathology

published in

1 reference

5 May 2018

volume

109

1 reference

5 May 2018

issue

3-4

1 reference

5 May 2018

page(s)

219-231

1 reference

5 May 2018

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

The interleukin 1 receptor: ligand interactions and signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Cytokine traps: multi-component, high-affinity blockers of cytokine action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

A bioassay for bovine interleukin-1 by the A375 cell growth inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

An mRNA homologous to interleukin-1 receptor type I is expressed in cultured rat sympathetic ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Molecular cloning of equine interleukin-1 alpha and -beta cDNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Enzymatic amplification and expression of bovine interleukin-1 receptor antagonist cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

The isolation of hybrid cell lines producing monoclonal antibodies against the p15(E) protein of ecotropic murine leukemia viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Effects of interleukin-1beta and tumor necrosis factor-alpha on expression of matrix-related genes by cultured equine articular chondrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

SMART, a simple modular architecture research tool: identification of signaling domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Cloning the interleukin 1 receptor from human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Interleukin 1 signaling occurs exclusively via the type I receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Co-expression of mRNA for type I and type II interleukin-1 receptors and the IL-1 receptor accessory protein correlates to IL-1 responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

Interleukin-1-like activity in synovial fluids and sera of horses with arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

inferred from DOI database lookup

7 January 2021

based on heuristic

Interleukin-1 stimulation of equine articular cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.08.018

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETIMM.2005.08.018

1 reference

5 May 2018

1 reference

5 May 2018